PROGRAM DESCRIPTION: Medical guidelines and PowerPoint presentations are a major snooze fest! It is tedious work to keep up with all that is new in food allergy. The presenters will offer a different way to learn; a variation of the traditional debate format called the “Car Talk” debate. Modeled after the format of the popular National Public Radio series, this session asks the presenters to explore the controversies surrounding food allergy by discussing an illustrative case and other questions posed by the audience.Initially, the focus will be on how we develop tolerance to food, why this process fails, and how an allergen is exposed/presented to the body plays a critical role in these events. The presenters will also take the audience through the groundbreaking Learning Early About Peanut allergy (LEAP) study, discussing the current recommendations, and what they mean to parents and physicians. They will review the new Addendum Guidelines for Prevention of Peanut Allergy in the U.S. The audience will be brought up to date on the current research on specific immunotherapy for food allergies, most notable peanut, including oral immunotherapy, sublingual immunotherapy, and epicutaneous immunotherapy, with discussion on the first therapy approved by the FDA for the treatment of food allergies. For the discussion, the presenters will identify controversies in food allergy and they will explore these controversies. This will be an engaging and fun session for both the attendees and the presenters.OUTCOME OBJECTIVE 1: Utilize diagnostic techniques in the evaluation and management of patients with food allergyOUTCOME OBJECTIVE 2: Review data regarding dietary interventions for the prevention of allergyOUTCOME OBJECTIVE 3: Summarize published updates on immunotherapy for food allergy, including the first FDA approved drug for treatment of peanut allergy for childrenBACKGROUND STATEMENT: Food allergy is rapidly developing field. Our members may not be aware of the guidelines for food allergy published a few years ago. It is definitely an exciting time in food allergy as the FDA recently approved the first drug for treatment of peanut allergy for children.
- Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
- Activity Link: http://media.mycrowdwisdom.com.s3.amazonaws.com/aao-hnsf/2023_Annual_Meeting_Webcasts/23AMW2409489.mp4
- Start Date: 2023-10-01 05:00:00
- End Date: 2023-10-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Otolaryngology